UBQLN1 (Ubiquilin 1)

A key regulator of protein degradation and quality control, implicated in neurodegenerative diseases and cancer.

Gene Information Card

Symbol UBQLN1
Full Name Ubiquilin 1
Gene Type Protein coding
Chromosomal Location 9q21.2
NCBI Gene ID 29979 ncbi.nlm.nih.gov/gene/29979
Ensembl ID ENSG00000135018
UniProt ID Q9UMX0
OMIM ID 605046
HGNC ID 12508
Aliases DA41, PLIC-1, hPLIC-1, UBQ-1

Description

UBQLN1 encodes ubiquilin 1, a member of the ubiquilin family that functions as a shuttle factor linking ubiquitinated proteins to the proteasome for degradation. It plays a critical role in protein quality control, autophagy, and stress response. The gene is widely expressed and has been associated with Alzheimer disease, frontotemporal dementia, and various cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Alzheimer disease UBQLN1 variants may alter APP processing and increase Aβ accumulation; impaired proteasomal degradation of tau PMID: 16936731; ClinVar
Frontotemporal dementia Loss of ubiquilin 1 function leads to TDP-43 aggregation and neuronal toxicity PMID: 23063122; OMIM
Breast cancer UBQLN1 overexpression correlates with poor prognosis; modulates ERα stability PMID: 25605248; COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 15.2 Medium
Heart 12.8 Medium
Liver 10.5 Medium
Kidney 14.1 Medium
Testis 18.3 High
Cell Line Expression
Cell Line nTPM Notes
HEK293 16.7 High expression
HeLa 14.2 Medium expression
SH-SY5Y 19.1 High expression
MCF7 12.3 Medium expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.146A>G (p.Asn49Ser) Missense <0.01% Altered protein stability; reported in Alzheimer disease
c.1073C>T (p.Pro358Leu) Missense <0.01% Reduced proteasome binding; associated with ALS
c.1300G>A (p.Glu434Lys) Missense <0.01% Unknown functional effect; rare population variant
Mutation functional classification

Loss of Function (LOF)

Missense variants (e.g., p.Asn49Ser) impair ubiquilin 1 binding to ubiquitinated substrates, reducing proteasomal degradation.

Gain of Function (GOF)

Not well documented; overexpression in cancer may enhance ERα signaling.

Dominant Negative (DN)

p.Pro358Leu may interfere with wild-type ubiquilin 1 function by competing for proteasome binding.

Pathways

• Proteasome-mediated ubiquitin-dependent protein catabolic process (Reactome: R-HSA-983168)
• Autophagy (KEGG: hsa04140)
• Ubiquitin mediated proteolysis (KEGG: hsa04120)

Protein Summary

Ubiquilin 1 is a 589-amino acid protein containing an N-terminal ubiquitin-like (UBL) domain and a C-terminal ubiquitin-associated (UBA) domain. It shuttles polyubiquitinated proteins to the proteasome and also participates in autophagy by interacting with LC3. The protein is expressed in multiple tissues, with highest levels in brain and testis. Post-translational modifications include phosphorylation and ubiquitination, which regulate its stability and function.

Related Products

Product name Cat.No. Species Gene ID
UBQLN1 Knockout HEK293 Cell Line EDJ-KQ194 Human 29979 Details Get a Quote
UBQLN1 Knockout HeLa Cell Line EDJ-KQ23964 Human 29979 Details Get a Quote
UBQLN1 Knockout A-549 Cell Line EDJ-KQ25340 Human 29979 Details Get a Quote
UBQLN1 Knockout HCT 116 Cell Line EDJ-KQ25341 Human 29979 Details Get a Quote
UBQLN1 Knockout Flp-In-T-REx-293 Cell Line EDJ-KZ72 Human 29979 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: